Posaconazole Tablet, Delayed Release
Product Images NDC 71335-2665

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 71335-2665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352665)

Label for Posaconazole Delayed-Release Tablets 100 mg, oral dosage form. The label indicates a package quantity of 60 tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by i3 Pharmaceuticals, LLC. It includes storage instructions, a warning that Noxafil oral suspension and delayed-release tablets are not interchangeable, and two QR codes for barcode and package insert access.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Posaconazole, depicted as a detailed molecular diagram showing its complex arrangement of rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.